期刊文献+

他汀类药的抗心律失常作用:从临床循证证据到分子机制 被引量:37

下载PDF
导出
摘要 临床和基础研究表明,他汀类药有抗心律失常作用。该类药物通过多效性机制,在降胆固醇以外,发挥抗炎、抗氧化、改善血管内皮细胞功能、影响血管生成、抑制心脏肥厚和左室重构、抑制神经内分泌激活等作用,甚至直接影响细胞膜离子通道功能,从而改善心肌细胞生存环境、提高心肌细胞电稳定性,减少心律失常的发生。已有的临床实验证据显示他汀对继发性心房颤动和特发性心房颤动、缺血性心脏病合并室性心律失常和非缺血性室性心律失常均有抑制作用。但亦有部分研究显示他汀并不具有抗心律失常作用。此有待更多的前瞻性、双盲、随机设计的多中心临床试验和深入的基础研究进一步明确他汀抗心律失常作用。
出处 《中国心脏起搏与心电生理杂志》 北大核心 2009年第5期377-381,共5页 Chinese Journal of Cardiac Pacing and Electrophysiology
  • 相关文献

参考文献36

  • 1Thambidorai SK, A_nand K, Hee Tr, et al. Hydroxymethylglutaryl coenzyme a inhibitors ( Statins ) and arrhythmias : systematic Review and Meta-Analysis [ J ]. The Internet Journal of Cardiology (网络版) ,2009,6(2).
  • 2Young XY,Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrilation in patients with coronary artery disease[ J]. Am J Cardiol,2003,92 ( 12 ) : 1 379.
  • 3Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery : results of the ARM YDA-3 ( atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study [ J ]. Circulation,2006,114 ( 14 ) : 1 455.
  • 4Marin F, Pascral DA, Roldan V, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting[ J ]. Am J Cardiol,2006,97 ( 1 ) :55.
  • 5Ozaydin M, Dogan A, Varol E, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation [ J ]. Cardiology,2006,107 (2) : 117.
  • 6Marisealco G, Lorusso R, Klersy C, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery [ J ]. Ann Thorae Surg,2007,84 (4) : 1 158.
  • 7Hanna IR, Heeke B, Bush H, et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction [ J ]. Heart Rhythm,2006,3 ( 8 ) : 881.
  • 8Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrenee by smfin therapy in patients with lone atrial fibrillation after successful eardioversion [ J ]. Am J Cardiol,2003,92 ( 11 ) : 1 343.
  • 9Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary disease: the Scandinavian Simvastatin Survival Study (4S) [J]. Lancet, 1994, 344 : 1 383.
  • 10Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J]. N Engl J Med,1998,339:1 349.

二级参考文献39

  • 1马天容,潘其兴,任蓓蓓,鹿庆华.阿托伐他汀对内皮细胞内皮脂酶mRNA表达的影响[J].山东大学学报(医学版),2005,43(5):407-410. 被引量:3
  • 2张繁之,王琳,张存泰,卜军,陈斌.阿托伐他汀对肥厚心肌缝隙连接重构的影响[J].中国现代医学杂志,2006,16(8):1145-1148. 被引量:5
  • 3Thambidorai SK, Anand K, Hee TT, et al. Hydroxymethylglutaryl coenzyme A inhibitors (statins) and arrhythmias: systematic review and meta-analysis [J]. The Internet Journal of Cardiology (网络版), 2009, 6(2).
  • 4Ramasubbu K, Estep J, White DL, et al. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy[J]. J Am Coll Cardiol, 2008, 51(4) : 415.
  • 5Vaquero M, Caballero R, Gomez R, et al. Effects of atorvastatin and simvastatin on atrial plateau currents [ J ]. J Mol Cell Cardiol, 2007, 42(5) : 931.
  • 6Starke-Peterkovic T, Turner N, Vitha MF, et al. Cholesterol effect on the dipole potential of lipid membranes [ J ]. Biophys J, 2006, 90 : 4 060.
  • 7Mason PR, Waiter MF, Day CA, et al. Intermolecular differences of 5-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions [ J ]. Am J Cardiol, 2005, 96 : 11F.
  • 8Gerber R, Ryan JD, Clark DS. Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS[J]. Anal Biochem, 2004, 329:28.
  • 9Cruz SL, Orta-Salazar G, Gauthereau MY, et al. Inhibition of cardiac sodium currents by toluene exposure [ J ]. Br J Pharmacol, 2003, 140:653.
  • 10Gauthereau MY, Stefanon EM, Cruz SL. A mutation in the local anaesthetic binding site abolishes toluene effects in sodium channels [J]. Eur J Pharmacol, 2005, 528:17.

共引文献10

同被引文献564

引证文献37

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部